Amgen Announces Repatha® Preferred Position On CVS Health Commercial Formularies
Go back to Amgen Announces Repatha® Preferred Position On CVS Health Commercial Formularies| Amgen Inc (NASDAQ: AMGN) | Delayed: 439.33 +5.60 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $433.73 | 52 Week High | $176.85 | |||
| Open | $431.72 | 52 Week Low | $133.64 | |||
| Day High | $440.51 | P/E | 66.16 | |||
| Day Low | $429.38 | EPS | $6.64 | |||
| Volume | 2,114,126 | |||||

